Effectiveness of Nutool & local application of Arq-e-Ajeeb in the management of Migraine.

A Clinical Study To Evaluate The Efficacy Of Arq-e-Ajeeb And Nutool-e-Raas With Roghan-e- Gul And Roghan-e-Kaddu In The Management Of Shaqiqa (Migraine Without Aura). - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071603

Enrollment

Registered

2024-07-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

Intervention1: Local application of Arq-e-Ajeeb and Nutool-e-Raas with Roghan-e-Gul & Roghan-e-Kaddu: Local application of Arq-e-Ajeeb when there is acute attack of migraine and 12 sittings of Nutool-

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed patients with migraine as per ICHD criteria. 2. Willing to fill daily headache diary. 3. Patient willing to sign written informed consent. 4. Patient who do report during follow-up (who follow instructions). 5. No systemic and local pathology.

Exclusion criteria

Exclusion criteria: 1. Patients below the age 18 years and above 60 years. 2. Non-Migrainous headache: tension type headache; cluster headache; chronic paroxysmal or non paroxysmal hemicranias. 3. Familial hemiplegic migraine 4. Any allergy related to drug used in this study. 5. Pregnancy and lactation. 6. Patients with Neuropsychiatric illness. 7. Patients with significant co-morbidity eg. Glaucoma, Trigeminal neuralgia, cervical spondylosis, Seizures disorders. 8. Patients who do not report for follow up and who refuses to join the study. 9. Patients on analgesic, steroidal and hormonal therapy.

Design outcomes

Primary

Measure	Time frame
1.VAS(Visual Analogue scale).Timepoint: For 1st month (twice in a week) For 2nd month (Once in a week)	—

Secondary

Measure	Time frame
MIDAS(Migraine Disability Assessment Scale). HIT-6(Headache impact test-6).Timepoint: 1st And Last Days of treatment	—

Countries

India

Contacts

Public ContactMohd Sajid

State Unani Medical College and Hospital, Himmatganj, Prayagraj, Uttar Pradesh (211016)

drbushraaftab@gmail.com8279747882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026